Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Paramus, New Jersey


Purpose:

The purpose of this phase 1 trial is to investigate the local tolerability on the finger following exposure to PEP005 Gel 0.015% or 0.05% and hand washing once daily, for 2 or 3 consecutive days.


Criteria:

Inclusion Criteria: - Must be male or female and at least 18 years of age - Female patients must be of: non-childbearing potential or if of childbearing potential then have a negative serum and urine pregnancy test and using effective contraception - Ability to provide informed consent Exclusion Criteria: - Have received treatment with immunomodulators, or interferon/interferon inducers or systematic medications that suppress the immune system in the last 4 weeks - Exposed to prescribed systemic (take as tablet, injection etc) or topical (gel, cream, lotion) medication within the last 7 days - Have any signs of skin irritation or damaged skin at or around the dominant index finger - Have worked in an occupation with a high risk of being in contact with irritative material (eg. chemicals, painting) on their hands, especially fingers - Those who are currently participating in any other clinical trial - Those known or suspected of not being able to comply with the requirements of the protocol - Females who are pregnant or are breastfeeding


NCT ID:

NCT01302925


Primary Contact:

Principal Investigator
Jonathan Dosik, MD
TKL Research


Backup Contact:

N/A


Location Contact:

Paramus, New Jersey
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.